Julie Louise Gerberding, M.D., MPH

Julie Louise Gerberding is the executive vice president and chief patient officer at Merck & Co. Inc., where she is responsible for patient engagement, strategic communications, global public policy, population health, and corporate responsibility. She joined Merck in 2010 as president of Merck vaccines.

Previously, Gerberding was the director of the U.S. Centers for Disease Control and Prevention, where she led the agency through more than 40 emergency responses to public health crises.

She received her undergraduate and medical degrees from Case Western Reserve University. She completed her internship and residency in internal medicine and a fellowship in clinical pharmacology and infectious diseases at the University of California, San Francisco, where she is currently an adjunct associate professor of medicine. Gerberding received a Master of Public Health at the University of California, Berkeley. She is a member of the National Academy of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians. She is board certified in internal medicine and infectious diseases.